BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37097644)

  • 41. Local excision of rectal cancer followed by radical surgery because of poor prognostic features does not compromise the long term oncologic outcome.
    Gagliardi G; Newton TR; Bailey HR
    Colorectal Dis; 2013 Nov; 15(11):e659-64. PubMed ID: 24033889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.
    Zhao M; Zhao L; Yang H; Duan Y; Li G
    Radiat Oncol; 2021 Jan; 16(1):17. PubMed ID: 33472660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".
    Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW
    Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol.
    Vatandoust S; Wattchow D; Sposato L; Michael MZ; Leung J; Gormly K; Chen G; Symonds EL; Tie J; Papanicolas LE; Woods S; Gebski V; Mead K; Kuruni A; Karapetis CS
    BMC Cancer; 2022 Mar; 22(1):222. PubMed ID: 35232427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.
    Li R; Wang Q; Zhang B; Yuan Y; Xie W; Huang X; Zhou C; Zhang S; Niu S; Chang H; Chen D; Miao H; Zeng ZF; Xiao W; Gao Y
    BMC Cancer; 2021 Dec; 21(1):1333. PubMed ID: 34906114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience.
    Lee WC; Yusof MM; Lau FN; Phua VC
    Asian Pac J Cancer Prev; 2013; 14(6):3941-4. PubMed ID: 23886211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of neoadjuvant therapy for the prognosis in patients with rectal carcinoma: a retrospective study.
    Li Q; Peng Y; Wang LA; Wei X; Li MX; Qing Y; Xia W; Cheng M; Zi D; Li CX; Wang D
    Tumour Biol; 2016 Mar; 37(3):3441-9. PubMed ID: 26449827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Skeletal muscle wasting and long-term prognosis in patients undergoing rectal cancer surgery without neoadjuvant therapy.
    Giani A; Famularo S; Fogliati A; Riva L; Tamini N; Ippolito D; Nespoli L; Braga M; Gianotti L
    World J Surg Oncol; 2022 Feb; 20(1):51. PubMed ID: 35216606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.
    Taieb J; Balogoun R; Le Malicot K; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Emile JF; Mulot C; Fratté S; Levaché CB; Saban-Roche L; Thaler J; Petersen LN; Bridgewater J; Perkins G; Lepage C; Van Cutsem E; Zaanan A; Laurent-Puig P;
    Ann Oncol; 2017 Apr; 28(4):824-830. PubMed ID: 28031175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series.
    Souadka A; Majbar MA; Benkabbou A; Serji B; Souiki T; Bouchentouf SM; Abid M; El Khannousi B; El Harroudi T; El Malki HO; Raiss M; Ifrine L; Mazaz K; Zentar A; Mohsine R; Souadka A; Belkouchi A; Ahallat M; Hrora A;
    BMC Cancer; 2019 Oct; 19(1):1008. PubMed ID: 31660903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study.
    Li J; Liu H; Yin J; Liu S; Hu J; Du F; Yuan J; Lv B; Fan J; Leng S; Zhang X
    Oncotarget; 2015 Dec; 6(39):42354-61. PubMed ID: 26472284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer.
    Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Morikawa T; Fukayama M; Watanabe T
    Dis Colon Rectum; 2017 Apr; 60(4):368-375. PubMed ID: 28267003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The importance of radiotherapy in rectal cancer-an update from a surgeon's perspective].
    Lauscher JC; Schineis CHW; Weixler B; Kreis ME
    Chirurg; 2021 Jul; 92(7):591-598. PubMed ID: 33893541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 58. Outcomes and Side Effects of Preoperative Chemoradiotherapy for Locally Advanced Upper Rectal Cancer.
    Chomicki S; Chapet S; Drifa M; Ouaissi M; Bourlier P; Debbi K; Loganadane G; Calais G
    Anticancer Res; 2022 Oct; 42(10):4833-4840. PubMed ID: 36192002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial.
    De Felice F; D'Ambrosio G; Iafrate F; Gelibter A; Magliocca FM; Musio D; Caponetto S; Casella G; Clementi I; Picchetto A; Sirgiovani G; Parisi M; Orciuoli C; Torrese G; De Toma G; Tombolini V; Cortesi E
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):788-794. PubMed ID: 34176711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients.
    Mei SW; Liu Z; Wei FZ; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Pei W; Wang Z; Wang XS; Liu Q
    World J Gastroenterol; 2020 Aug; 26(31):4624-4638. PubMed ID: 32884221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.